Teva to obtain U.S. commercialization rights for two immunology biosimilars: ETICOVO ® upon close and infliximab-abda in Q3 2027; Collaboration combines Samsung Bioepis biosimila ...
Environmental Tectonics Corporation (OTCID: ETCC) (ETC or the Company) was named to TIMEs annual list of Americas Growth ...
Establishes onsemi as a leader in integrated voltage regulator (IVR) technology with best-in-class power density required for ...
The Middle East conflict has tested ADNOC, Saudi Aramco and QatarEnergy, while highlighting sharp differences in export flexibility and portfolio diversification. Although all three companies remain ...
Roy Jakobs, CEO of Royal Philips: We delivered an excellent 8% comparable order intake, led by broad-based order momentum in Diagnosis & Treatment, and 3% comparable sales growth in the third quarter, ...
More than 2 billion people globally live with vision impairment. For 1 billion of them, their sight loss is entirely preventable or treatable, but basic eye care is often unaffordable or inaccessible.
Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, ...
Nós utilizamos cookies e outras tecnologias semelhantes para melhorar sua experiência em nossos serviços, personalizar nossa ...
BHAV Acquisition Corp II (the Company or BHAV) today announced the pricing of its initial public offering of 10,000,000 units ...
Nós utilizamos cookies e outras tecnologias semelhantes para melhorar sua experiência em nossos serviços, personalizar nossa ...
For a business traveller, landing often means getting straight back to work: downloading a presentation or replying to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results